InvestorsHub Logo
Followers 93
Posts 21466
Boards Moderated 0
Alias Born 06/07/2011

Re: Garden Rose post# 1528

Wednesday, 05/12/2021 2:17:18 PM

Wednesday, May 12, 2021 2:17:18 PM

Post# of 23069
You are misinformed-no you are

You have outdated studies and not current.



Wrong. How much more recent do you want than

JAMA

published findings on November 9, 2020

The 479 patients who enrolled were randomly assigned to receive hydroxychloroquine or a placebo. The trial included 290 Latino and Black participants. The median patient age was 57. They received 10 doses of either hydroxychloroquine or a placebo over five days (400 mg twice daily on the first day, then 200 mg twice daily for the following four days).

Researchers assessed each patient’s condition 14 days after being assigned to a treatment group. They used a seven-category scale ranging from one (death) to seven (discharged from the hospital and able to perform normal activities). The results showed no significant difference between the hydroxychloroquine and placebo groups.

The scientists also found no differences in any of 12 additional outcomes, which included mortality 28 days after assignment to a treatment group or time to recovery. Based on the data, they concluded that hydroxychloroquine was not an effective treatment.



Or how about

22-Apr-2021

Is that also suppose to be "outdated"?

There were no significant differences between the interventions and the placebo group for coronavirus-related hospitalization (hazard ratio [HR] for hydroxychloroquine, 0.76; HR for lopinavir-ritonavir, 1.16). Nor were there substantial differences for viral clearance through day 14 (odds ratio [OR] for hydroxychloroquine, 0.91; OR for lopinavir-ritonavir, 1.04) or for symptom resolution.

The authors said that their study adds to mounting evidence that hydroxychloroquine and lopinavir-ritonavir shouldn't be used in the treatment of COVID-19. "



Here's another "outdated" one

March 2021

Neither HCQ nor HCQ/AZ shortened the clinical course of outpatients with COVID-19, and HCQ, but not HCQ/AZ, had only a modest effect on SARS-CoV-2 viral shedding. HCQ and HCQ/AZ are not effective therapies for outpatient treatment of SARV-CoV-2 infection.[/quote]

One more time

Among patients hospitalized with Covid-19, those who received hydroxychloroquine did not have a lower incidence of death at 28 days than those who received usual care.



It is far more dangerous to recommend that a person



be given HCQ. About as useful as a sugar pill.

be subjected to an experiment with unknown long term consequences



Once again I invite you to explain on the molecular level how any component of the Pfizer or mRNA vaccine has the potential for these imaginary "long term consequences". The molecular basis for them occurring.

when there are less risky remedies available.



HCQ and Ivermectin are extremely risky. As in being worthless against Covid infection. Kick the patient out of the hospital, and give them pills that do nothing . Might as well not treat em, or give them sugar pills. Or one can avoid the problem, and just get vaccinated with a mRNA vaccine.



The Jewel of the Mind is Colored with the Hue of what it Imagines

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.